⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29493168 | 1.00 | — | — | |
| SCHEMBL11789180 | 1.00 | — | — | |
| SCHEMBL29351616 | 1.00 | — | — | |
| SCHEMBL10384729 | 1.00 | — | — | |
| SCHEMBL10903486 | 1.00 | — | — | |
| SCHEMBL176391 | 1.00 | — | — | |
| SCHEMBL29450510 | 1.00 | — | — | |
| SCHEMBL30115076 | 1.00 | — | — | |
| SCHEMBL8066885 | 1.00 | — | — | |
| SCHEMBL5200948 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332298-A1 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | BLUE WAVE THERAPEUTICS GMBH (CH) | 2025-10-30 | — | — | US | claimed |
| EP-4419151-A1 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | Blue Wave Therapeutics GmbH (CH) | 2024-08-28 | — | — | EP | claimed |
| CN-118139650-A | Peptide-coupled alginate gels including radionuclides | 蓝波医疗有限责任公司 | 2024-06-04 | — | — | CN | claimed |
| WO-2023066994-A1 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | BLUE WAVE THERAPEUTICS GMBH (CH) | 2023-04-27 | — | — | WO | claimed |
| EP-4718474-A2 | INTEGRATED ISOTOPE BATTERY | LG Energy Solution, Ltd. (KR) | 2026-04-01 | — | — | EP | disclosed |
| US-20260084978-A1 | PROCESS FOR PRODUCING ATOMIC QUANTUM CLUSTERS DERIVATIVES | NANOGAP SUB NM POWDER S A (ES) | 2026-03-26 | — | — | US | disclosed |
| US-20260085064-A1 | SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF | KARYOPHARM THERAPEUTICS INC (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4715841-A1 | INTEGRATED ISOTOPE BATTERY | LG Energy Solution, Ltd. (KR) | 2026-03-25 | — | — | EP | disclosed |
| EP-4709424-A1 | LYOPHILIZED PRODUCTS, PHARMACEUTICAL COMPOSITIONS, AND KITS COMPRISING DYE-PEPTIDE CONJUGATES AND DERIVATIVES | Integro Theranostics, LLC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12577225-B2 | Nuclear transport modulators and uses thereof | Karyopharm Therapeutics Inc. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12573517-B2 | Methods for producing radionuclides | BATTELLE ENERGY ALLIANCE, LLC (US) | 2026-03-10 | — | — | US | disclosed |
| EP-4700796-A1 | STACK-TYPE ISOTOPE BATTERY | LG Energy Solution, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| US-20220135545-A1 | POLYMORPHS OF SELINEXOR | Karyopharm Therapeutics Inc. | 2022-05-05 | — | — | US | disclosed |
| EP-3990042-A1 | OCULAR DEVICE DELIVERY METHODS AND SYSTEMS | Layerbio, Inc. (US) | 2022-05-04 | — | — | EP | disclosed |
| CN-108440515-B | Substituted benzofuranyl and benzoxazolyl compounds and uses thereof | 卡尔约药物治疗公司 | 2022-05-03 | — | — | CN | disclosed |
| US-11318120-B2 | Nuclear transport modulators and uses thereof | BIOGEN MA INC. (US) | 2022-05-03 | — | — | US | disclosed |
| CN-114340690-A | Ocular device delivery methods and systems | 雷尔生物公司 | 2022-04-12 | — | — | CN | disclosed |
| EP-3962498-A1 | COMBINATION THERAPIES | Memorial Sloan Kettering Cancer Center (US) | 2022-03-09 | — | — | EP | disclosed |
| US-20220054550-A1 | COMBINATION THERAPIES | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-02-24 | — | — | US | disclosed |
| CN-114025775-A | Combination therapy | 纪念斯隆-凯特琳癌症中心 | 2022-02-08 | — | — | CN | disclosed |